<script>
        const allPosts = [
            { 
                cat: 'medical', 
                title: 'T-Cell Regulation in Psoriasis', 
                excerpt: 'Analyzing the latest research on IL-23 pathways and biologics.', 
                date: 'Jan 12', 
                icon: 'M14.5,18C14.5,19.33 13.11,20.39 12,21C10.89,20.39 9.5,19.33 9.5,18C9.5,17.45 9.75,16.96 10.15,16.62C9.28,15.82 8.41,14.88 7.55,13.81C6.9,13 6.31,12.16 5.86,11.36C4.89,11.77 3.86,11.79 3,11.33C1.5,10.5 1.5,8.5 3.5,8C3.89,7.9 4.31,7.9 4.75,8C4.61,7.32 4.54,6.65 4.54,6C4.54,3.24 6.78,1 9.54,1C10.45,1 11.3,1.25 12,1.68C12.7,1.25 13.55,1 14.46,1C17.22,1 19.46,3.24 19.46,6C19.46,6.65 19.39,7.32 19.25,8C19.69,7.9 20.11,7.9 20.5,8C22.5,8.5 22.5,10.5 21,11.33C20.14,11.79 19.11,11.77 18.14,11.36C17.69,12.16 17.1,13 16.45,13.81C15.59,14.88 14.72,15.82 13.85,16.62C14.25,16.96 14.5,17.45 14.5,18M12,19C12.55,19 13,18.55 13,18C13,17.45 12.55,17 12,17C11.45,17 11,17.45 11,18C11,18.55 11.45,19 12,19M12,4C11.1,4 10.3,4.4 9.7,5C10.3,5.6 11.1,6 12,6C12.9,6 13.7,5.6 14.3,5C13.7,4.4 12.9,4 12,4Z' 
            },
            { cat: 'aesthetics', title: 'Volumetric Restoration', excerpt: 'Structural support using high G-prime fillers for facial harmony.', date: 'Jan 10', icon: 'M12,2L1,21H23L12,2M12,6L19.53,19H4.47L12,6Z' },
            { 
                cat: 'skincare', 
                title: 'Molecular Retinoids', 
                excerpt: 'The evolution of tretinoin and irritation-free derivatives.', 
                date: 'Jan 08', 
                icon: 'M19,19H5V11H19M19,9H5A2,2 0 0,0 3,11V19A2,2 0 0,0 5,21H19A2,2 0 0,0 21,19V11A2,2 0 0,0 19,9M17,7H7V5H17M17,3H7A2,2 0 0,0 5,5V7A2,2 0 0,0 7,9H17A2,2 0 0,0 19,7V5A2,2 0 0,0 17,3Z' 
            },
            { 
                cat: 'leadership', 
                title: 'The Physician Executive', 
                excerpt: 'Transitioning clinical excellence to board-level leadership.', 
                date: 'Jan 05', 
                // NEW ATTACHMENT-INSPIRED LEADERSHIP ICON (STRATEGIC CHESS KING)
                icon: 'M19,22H5V20H19V22M17,10C15.58,10 14.26,10.77 13.5,12C13.28,11.39 12.7,11 12,11C11.3,11 10.72,11.39 10.5,12C9.74,10.77 8.42,10 7,10A4,4 0 0,0 3,14C3,15.14 3.47,16.17 4.23,16.91C4.46,17.13 4.71,17.34 5,17.5V19H19V17.5C19.29,17.34 19.54,17.13 19.77,16.91C20.53,16.17 21,15.14 21,14A4,4 0 0,0 17,10M12,2L10,5H14L12,2Z' 
            },
            { cat: 'finance', title: 'Practice Valuation', excerpt: 'Understanding EBITDA and equity for private practitioners.', date: 'Jan 02', icon: 'M16,11.78L20.24,4.45L21.97,5.45L16.74,14.5L10.23,10.75L5.46,19H22V21H2V3H4V17.54L9.5,8L16,11.78Z' }
        ];

        // ... rest of the render and filtering scripts ...
    </script>
